A Talk With Beckman Coulter CEO Scott Garrett, New Chair Of AdvaMed Dx
This article was originally published in The Gray Sheet
Executive Summary
After years of debating whether to form their own trade association or stay under the big tent with the device industry's leading advocacy group, AdvaMed, diagnostics companies may now have the best of both worlds, says Scott Garrett
You may also be interested in...
Beckman CEO Resigns As Company Faces Regulatory Challenges
Beckman Coulter announced the resignation of Scott Garrett as chairman, president and CEO Sept. 7 as the firm tries to recover from a recent FDA-triggered diagnostic test market withdrawal and ongoing regulatory scrutiny
Beckman CEO Resigns As Company Faces Regulatory Challenges
Beckman Coulter announced the resignation of Scott Garrett as chairman, president and CEO Sept. 7 as the firm tries to recover from a recent FDA-triggered diagnostic test market withdrawal and ongoing regulatory scrutiny
AdvaMed Begets "AdvaMed Dx" For IVD-Focused Lobbying Effort
AdvaMed is forming an "association within an association" to focus exclusively on in vitro diagnostics, the group announced Dec. 17